Regulatory Effect of N6-methyladenosine on Tumor Angiogenesis

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Sep 19

PMID 39295872

Authors

YuYan

Enwu Yuan

Affiliations

Soon will be listed here.

Abstract

Previous studies have demonstrated that genetic alterations governing epigenetic processes frequently drive tumor development and that modifications in RNA may contribute to these alterations. In the 1970s, researchers discovered that N6-methyladenosine (mA) is the most prevalent form of RNA modification in advanced eukaryotic messenger RNA (mRNA) and noncoding RNA (ncRNA). This modification is involved in nearly all stages of the RNA life cycle. MA modification is regulated by enzymes known as mA methyltransferases (writers) and demethylases (erasers). Numerous studies have indicated that mA modification can impact cancer progression by regulating cancer-related biological functions. Tumor angiogenesis, an important and unregulated process, plays a pivotal role in tumor initiation, growth, and metastasis. The interaction between mA and ncRNAs is widely recognized as a significant factor in proliferation and angiogenesis. Therefore, this article provides a comprehensive review of the regulatory mechanisms underlying mA RNA modifications and ncRNAs in tumor angiogenesis, as well as the latest advancements in molecular targeted therapy. The aim of this study is to offer novel insights for clinical tumor therapy.

Citing Articles

RNA Modification in Metabolism.

Liu Y, Sun Z, Gui D, Zhao Y, Xu Y MedComm (2020). 2025; 6(3):e70135.

PMID: 40066222 PMC: 11892166. DOI: 10.1002/mco2.70135.

References

Knuckles P, Lence T, Haussmann I, Jacob D, Kreim N, Carl S . Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the mA machinery component Wtap/Fl(2)d. Genes Dev. 2018; 32(5-6):415-429. PMC: 5900714. DOI: 10.1101/gad.309146.117. View

Wang N, Huo X, Zhang B, Chen X, Zhao S, Shi X . METTL3-Mediated ADAMTS9 Suppression Facilitates Angiogenesis and Carcinogenesis in Gastric Cancer. Front Oncol. 2022; 12:861807. PMC: 9097454. DOI: 10.3389/fonc.2022.861807. View

Rong D, Dong Q, Qu H, Deng X, Gao F, Li Q . mA-induced LINC00958 promotes breast cancer tumorigenesis via the miR-378a-3p/YY1 axis. Cell Death Discov. 2021; 7(1):27. PMC: 7854648. DOI: 10.1038/s41420-020-00382-z. View

Huff S, Kummetha I, Zhang L, Wang L, Bray W, Yin J . Rational Design and Optimization of mA-RNA Demethylase FTO Inhibitors as Anticancer Agents. J Med Chem. 2022; 65(16):10920-10937. PMC: 9421652. DOI: 10.1021/acs.jmedchem.1c02075. View

Han M, Sun H, Zhou Q, Liu J, Hu J, Yuan W . Effects of RNA methylation on Tumor angiogenesis and cancer progression. Mol Cancer. 2023; 22(1):198. PMC: 10698974. DOI: 10.1186/s12943-023-01879-8. View

He P, He C . m A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 2021; 40(3):e105977. PMC: 7849164. DOI: 10.15252/embj.2020105977. View

Lopes-Coelho F, Martins F, Pereira S, Serpa J . Anti-Angiogenic Therapy: Current Challenges and Future Perspectives. Int J Mol Sci. 2021; 22(7). PMC: 8038573. DOI: 10.3390/ijms22073765. View

Fang H, Sun Q, Zhou J, Zhang H, Song Q, Zhang H . mA methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma. Mol Cancer. 2023; 22(1):99. PMC: 10288689. DOI: 10.1186/s12943-023-01791-1. View

Wen J, Xue L, Wei Y, Liang J, Jia W, Yong T . YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD-L1/VEGFA Axis. Adv Sci (Weinh). 2024; 11(13):e2307242. PMC: 10987122. DOI: 10.1002/advs.202307242. View

10.

Zhou Y, Mao X, Peng R, Bai D . CircRNAs in hepatocellular carcinoma: characteristic, functions and clinical significance. Int J Med Sci. 2022; 19(14):2033-2043. PMC: 9724243. DOI: 10.7150/ijms.74713. View

11.

Mauer J, Jaffrey S . FTO, m A , and the hypothesis of reversible epitranscriptomic mRNA modifications. FEBS Lett. 2018; 592(12):2012-2022. DOI: 10.1002/1873-3468.13092. View

12.

Dong L, Chen C, Zhang Y, Guo P, Wang Z, Li J . The loss of RNA N-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8 T cell dysfunction and tumor growth. Cancer Cell. 2021; 39(7):945-957.e10. DOI: 10.1016/j.ccell.2021.04.016. View

13.

Chen L, Yang L . Regulation of circRNA biogenesis. RNA Biol. 2015; 12(4):381-8. PMC: 4615371. DOI: 10.1080/15476286.2015.1020271. View

14.

Liu Y, Liang G, Xu H, Dong W, Dong Z, Qiu Z . Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. Cell Metab. 2021; 33(6):1221-1233.e11. DOI: 10.1016/j.cmet.2021.04.001. View

15.

Tuersun H, Liu L, Zhang J, Maimaitizunong R, Tang X, Li H . m6A reading protein RBMX as a biomarker for prognosis and tumor progression in esophageal cancer. Transl Cancer Res. 2023; 12(9):2319-2335. PMC: 10583014. DOI: 10.21037/tcr-23-84. View

16.

Sun H, Li K, Zhang X, Liu J, Zhang M, Meng H . mAm-seq reveals the dynamic mAm methylation in the human transcriptome. Nat Commun. 2021; 12(1):4778. PMC: 8346571. DOI: 10.1038/s41467-021-25105-5. View

17.

Li Z, Feng Y, Han H, Jiang X, Chen W, Ma X . A Stapled Peptide Inhibitor Targeting the Binding Interface of N6-Adenosine-Methyltransferase Subunits METTL3 and METTL14 for Cancer Therapy. Angew Chem Int Ed Engl. 2024; 63(24):e202402611. DOI: 10.1002/anie.202402611. View

18.

Kane S, Beemon K . Precise localization of m6A in Rous sarcoma virus RNA reveals clustering of methylation sites: implications for RNA processing. Mol Cell Biol. 1985; 5(9):2298-306. PMC: 366956. DOI: 10.1128/mcb.5.9.2298-2306.1985. View

19.

Hou P, Fan Q, Zhang Q, Liu J, Wu Q . M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C. Clin Exp Pharmacol Physiol. 2024; 51(7):e13868. DOI: 10.1111/1440-1681.13868. View

20.

Takahashi H, Shibuya M . The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond). 2005; 109(3):227-41. DOI: 10.1042/CS20040370. View